NCT04437745已完成不适用
A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face
LG Chem1 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2020年11月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 238
- 试验地点
- 1
- 主要终点
- Asian Faces Mid-Face Volume Deficit Severity Rating Scale (MFVDA-SRS) responder rate
研究概览
简要总结
To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or female adults 18 to 65 years of age (inclusive)
- •3 (moderate) or 4 (severe) on MFVDA-SRS
- •sign the written informed consent form
排除标准
- •have streptococcal disease or bleeding disorder
- •have an active or infective skin disease, scars, or tumor on mid-face
- •have congenital defect, trauma, abnormalities in adipose tissue related to immune-mediated diseases
- •have undergone facial plastic surgery, tissue grafting, or tissue augmentation with silicone, fat, or other permanent, or semi-permanent procedures/treatment
- •have undergone temporary facial dermal filler within 12 months, porcine-based collagen fillers within 24 months, or neuromodulator injections, mesotherapy, or resurfacing within 6 months
- •have a medical history of hypertrophic cicatrix or keloid
- •have radiation therapy experience on mid-face
- •have a history of anaphylaxis, multiple severe allergies, atopy, or allergy to lidocaine, hyaluronic acid products, or Streptococcal protein
结局指标
主要结局
Asian Faces Mid-Face Volume Deficit Severity Rating Scale (MFVDA-SRS) responder rate
时间窗: 26 weeks from baseline
the proportion of subjects with ≥1-grade reduction on the MFVDA-SRS score (The MFVDA-SRS score ranges from 1-4 with higher score indicating increasing severity of mid-face volume deficit.)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
A Study of YVOIRE Y-Solution 360 for Hand Augmentation to Correct Volume LossDorsal Hand Volume LossNCT04112017LG Chem116
已完成
不适用
Effectiveness and Safety of YVOIRE Y-Solution 540Wrinkles in the Nasolabial FoldsNCT04855188LG Chem394
终止
不适用
To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area.Lip AugmentationNCT04299295LG Chem118
已完成
不适用
Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold InjectionTemporary Correction of WrinklesNCT03738007LG Life Sciences57
已完成
不适用
To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face VolumeMidface Volume DeficitNCT04784299LG Chem105
